Comparison of Subcutaneous and Intravenous Administration of a Solution of Aminoacids in Older Patients
Autor: | Thierry Constans, Xavier Leverve, Monique Ferry |
---|---|
Přispěvatelé: | Service de gériatrie, Centre hospitalier de Valence, Bioénergétique fondamentale et appliquée, Université Joseph Fourier - Grenoble 1 (UJF)-Institut National de la Santé et de la Recherche Médicale (INSERM), Gériatrie, Université de Tours, Université de Tours (UT), Hamant, Sarah |
Rok vydání: | 1997 |
Předmět: |
Male
MESH: Nutritional Support medicine.medical_specialty MESH: Amino Acids Injections Subcutaneous MESH: Solutions Protein-Energy Malnutrition MESH: Cross-Over Studies Route of administration MESH: Aged 80 and over Older patients [SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular Biology medicine Humans [SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular Biology Prospective Studies Amino Acids Nitrogen supplementation Infusions Intravenous MESH: Infusions Intravenous Aged Aged 80 and over MESH: Aged Baseline values Osmole Cross-Over Studies MESH: Humans Nutritional Support business.industry MESH: Injections Subcutaneous Mean age Protein intake MESH: Prospective Studies MESH: Protein-Energy Malnutrition MESH: Male Surgery Solutions Anesthesia Female Geriatrics and Gerontology business MESH: Female |
Zdroj: | Journal of the American Geriatrics Society Journal of the American Geriatrics Society, Wiley, 1997, 45 (7), pp.857-60 |
ISSN: | 0002-8614 1532-5415 |
DOI: | 10.1111/j.1532-5415.1997.tb01515.x |
Popis: | International audience; OBJECTIVE: To compare the plasma amino acid (AA) concentrations obtained by the infusion of an AA solution (660 mOsm/L, pH 7) using the subcutaneous (SC) with that using the intravenous (i.v.) route in older patients. DESIGN: A prospective, randomized, cross-over study. SETTING: A hospital geriatric ward. PARTICIPANTS: Six patients with a mean age of 84 years. MEASUREMENTS: The infusion of the AA solution (IV or SC) lasted 6 hours. Blood was sampled at 0, 2, 4, 6, 8, 10, 14, 18, and 24 hours from the start of the infusion to determine plasma AA level by the phenyl-isothiocyanate method. RESULTS: Compared with baseline values, plasma AA concentrations increased to a significantly higher level from the second to the tenth hour and from the second to the fourteenth hour during i.v. and SC infusions, respectively. Plasma AA levels did not differ between the two routes. SC infusion was well tolerated. CONCLUSION: Assuming that nutritional sufficiency is the desired result of plasma AA infusion, we conclude the SC route is well tolerated and offers the possibility of nitrogen supplementation for older patients over short periods of time, when oral protein intake is transiently insufficient or impossible, as a way to limit, but not to treat, protein-energy malnutrition. |
Databáze: | OpenAIRE |
Externí odkaz: |